Search
for
Sort by
Research 661–690 of 1000+
- The relative effect of monotherapy with 5‐alpha reductase inhibitors and minoxidil for female pattern hair loss: A network meta‐analysis study
- Lineage Analysis of Epidermal Stem Cells
- Alexithymia and Cutaneous Disease Morbidity: A Systematic Review
- Antiepileptogenic effects of trilostane in the kainic acid model of temporal lobe epilepsy
- Reporting in clinical studies on platelet-rich plasma therapy among all medical specialties: A systematic review of Level I and II studies
- Reporting Live from the Epidermal Stem Cell Compartment!
- Reporting Cases of Telogen Effluvium as a sequelae of COVID‐19 Infection
- Reporting Quality of Drug Safety Systematic Reviews: A Cross-Sectional Study
- Reporting on Adverse Clinical Events
- Reporting on Adverse Clinical Events
- Reporting on Adverse Clinical Events
- Reporting on Adverse Clinical Events
- Adverse Event Reporting in Clinical Trials of Finasteride for Androgenic Alopecia: A Meta-analysis.
- The Wound Reporting in Animal and Human Preclinical Studies (WRAHPS) Guidelines
- Evaluating the quality of studies reporting on clinical applications of stromal vascular fraction: A systematic review and proposed reporting guidelines (CLINIC-STRA-SVF)
- Minimum requirements for reporting clinical trials evaluating the therapeutic potential of platelet-rich plasma
- Discrepancies in safety reporting for chronic back pain clinical trials: an observational study from ClinicalTrials.gov and publications
- (719) Signal Detection of Depression and Suicidality With the 5-Alpha Reductase Inhibitors: Evidence from the Food and Drug Administration (FDA) Adverse Event Reporting System (FAERS) Database
- Association of alopecia areata with COVID-19 vaccination: A vaccine adverse events reporting system analysis
- Drug related lipid metabolism abnormalities: a real-world pharmacovigilance exploratory analysis based on U.S. FDA adverse event reporting system (FAERS)
- Cyclosporine-induced alopecia:a case report, FDA adverse event reporting system analysis and literature assessment
- Correction to: An evaluation of the federal adverse events reporting system data on adverse effects of 5‑alpha reductase inhibitors
- Method for chronological recording of antigen appearance in human head-hair shafts and its use for monitoring glycation products in diabetes
- LOCAL IRRITANT AND SKIN RESORBING EFFECT OF ZINC HYDROCARBONATE NANOPARTICLES STABILIZED BY POLYVINYLPYRROLIDONE
- Regal Hair Salon: Tax and financial reporting of gift cards
- Response to: “Minimum requirements for reporting clinical trials evaluating the therapeutic potential of platelet-rich plasma”
- Evaluating the safety profile of α-1 blockers, 5α-reductase inhibitors, and PDE5I for BPH: a disproportionality analysis of real-world adverse events based on FDA adverse event reporting system (FAERS)
- Assessment of Quality of Life in Patients Reporting with Dermatological Conditions to a Primary Healthcare Setting in Goa, India.
- Iron-deficient erythropoiesis in women reporting diffuse scalp hair loss.
- Rebuilding Trust: Novel Standards for Reporting the Effectiveness of Male-Pattern Hair Loss Treatment